Detalhe da pesquisa
1.
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.
Cancer;
2024 May 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38752572
2.
Prevalence of targetable genomic alterations in young women with advanced breast cancer: a cross-sectional study.
Breast Cancer Res Treat;
204(1): 181-185, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37999916
3.
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
JAMA;
331(1): 49-59, 2024 01 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38059899
4.
Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay.
Oncologist;
28(10): e973-e976, 2023 10 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37656608
5.
PD-L1 protein expression in relation to recurrence score values in early-stage ER + breast cancer.
Breast Cancer Res Treat;
196(1): 221-227, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36028784
6.
Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy.
Breast Cancer Res;
23(1): 14, 2021 01 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33514405
7.
Optimal Management for Residual Disease Following Neoadjuvant Systemic Therapy.
Curr Treat Options Oncol;
22(9): 79, 2021 07 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34213636
8.
Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.
J Allergy Clin Immunol;
135(1): 153-63, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25567045
9.
RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications.
J Allergy Clin Immunol;
135(5): 1218-27, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25840722
10.
Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin.
J Allergy Clin Immunol;
135(3): 712-20, 2015 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25583101
11.
Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response.
J Allergy Clin Immunol;
134(2): 362-72, 2014 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24768652
12.
Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.
J Allergy Clin Immunol;
133(6): 1626-34, 2014 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24786238
13.
The correlation of ESR1 genetic aberrations with estrogen receptor and progesterone receptor status in metastatic and primary estrogen receptor-positive breast carcinomas.
Hum Pathol;
137: 56-62, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37127079
14.
More than bad luck: Cancer and aging are linked to replication-driven changes to the epigenome.
Sci Adv;
9(29): eadf4163, 2023 07 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37467337
15.
Evidence of accelerated epigenetic aging of breast tissues in patients with breast cancer is driven by CpGs associated with polycomb-related genes.
Clin Epigenetics;
14(1): 30, 2022 02 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35209953
16.
Cancer Relevance of Human Genes.
J Natl Cancer Inst;
114(7): 988-995, 2022 07 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35417011
17.
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers.
NPJ Breast Cancer;
8(1): 119, 2022 Nov 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36344517
18.
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer.
Clin Cancer Res;
28(12): 2587-2597, 2022 06 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35377948
19.
Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence.
J Allergy Clin Immunol;
134(4): 955-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24996261
20.
Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers.
J Immunother Cancer;
8(2)2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33239417